A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma

  • STATUS
    Recruiting
  • participants needed
    3100
  • sponsor
    Bond Avillion 2 Development LP
Updated on 30 November 2021
corticosteroids
budesonide
forced expiratory volume
albuterol
spirometry
leukotriene receptor antagonist
theophylline
peak expiratory flow
muscarinic antagonists

Summary

This is a randomized, double-blind, multicenter, parallel-group, variable-length study to compare 2 doses of BDA MDI (PT027) with AS MDI (PT007) on the time to first severe asthma exacerbation in adult, adolescent, and pediatric subjects with moderate to severe asthma.

Details
Condition Asthma, Allergies & Asthma, Asthma (Pediatric), asthmatic, bronchial asthma
Treatment Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg, Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg, Albuterol sulfate metered-dose inhaler 180 μg
Clinical Study IdentifierNCT03769090
SponsorBond Avillion 2 Development LP
Last Modified on30 November 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note